Explore by Goal

Quick Explanation Copied

Author snapshot — Lindsey R. Robinson‑McCarthy

Active virology/biology author (OpenAlex: 24 works, 1,171 citations, h‑index 10) with high‑impact coauthorships on SARS‑CoV‑2 and influenza surrogate systems; strengths: experimental virology, viral entry/antibody escape, reproducible in vitro methods; blindspots: limited first‑author corpus, mainly middle/last author contributions, and reliance on in vitro/surrogate systems for translational claims ().

Long Explanation

Author Review — Lindsey R. Robinson‑McCarthy

Key quantitative metrics (OpenAlex)

Works: 24
Total citations: 1,171
h‑index: 10

These reflect a researcher with solid community impact, especially via high‑visibility coauthored papers in top journals (Science, mBio, Nature Microbiology, PLoS Pathogens, Journal of Virology).

Top thematic focus & representative high‑impact work

Robinson‑McCarthy's publications cluster in virology — viral entry, antibody responses, and surrogate systems for high‑consequence agents. Representative, high‑impact contributions include middle‑author roles on papers that reshaped understanding of antigenic escape and viral entry, plus first‑author work reconstructing extinct viral entry pathways.

Representative citations (selected):

Scientific strengths

Experimental competency across virology techniques (pseudotyping, neutralization assays, sequencing, structural collaborations) demonstrated in first‑ and middle‑author papers.
Coauthorship on multiple high‑visibility, high‑impact multidisciplinary papers (Science, Sci Transl Med) — indicates capacity to work in collaborative, rigorous teams.
Work that spans basic mechanism (receptor/entry) to applied concerns (diagnostic artifacts, surrogate systems), showing methodological breadth.

Limitations, blindspots, and potential biases

Many contributions are middle‑author on multi‑laboratory efforts; while valuable, this makes attribution of independent intellectual leadership harder to assess from bibliometrics alone.
Several studies rely on in vitro or surrogate viral systems (e.g., VSV pseudotypes, diagnostic spike‑ins). These accelerate safe experimentation but may over‑ or under‑estimate effects in authentic in vivo infection contexts ().
Relatively small first‑author publication count versus coauthorships; independent program leadership and PI‑level grants are not evident from provided metadata (no primary institution listed), which may limit evaluation of independent research trajectory.
Potential publication and collaboration biases typical to high‑impact labs (positive‑result bias, multi‑author credit dilution) should be considered when extrapolating individual contribution from citation counts.

Practical assessment — where the author adds the most value

Contributing experimental expertise within teams studying viral entry, antigenic evolution, and diagnostic artifacts.
Producing reproducible in vitro assay work (pseudotypes, neutralization) that supports rapid, lower‑biosafety exploration of high‑concern glycoproteins.
Bridging mechanistic virology with translational concerns (diagnostics, vector design), making contributions useful for both basic and applied research communities.

What would materially strengthen the author's scientific profile?

More independent first‑author, hypothesis‑driven studies with explicit data and code availability to increase attribution and reproducibility.
Integration of in vitro/surrogate findings with validated authentic virus or in vivo data (or systematic cross‑validation studies) to quantify surrogate predictiveness.
Clearer public statements of funding, COI, and institutional affiliation to improve transparency in research provenance.

Concluding evaluation (evidence‑weighted)

Robinson‑McCarthy is a productive experimental virologist embedded in high‑impact collaborative teams. The record shows methodological competence, useful cross‑disciplinary contributions, and influence via coauthorship on several highly cited papers. The main scientific caveats are (i) relatively fewer sole/first‑author flagship papers to trace independent conceptual leadership, and (ii) reliance in multiple works on surrogate/in vitro systems whose translational generality is explicitly limited by the authors themselves ().

Selected raw evidence links

Next steps / actions you can run

If you want deeper attribution analysis (author contribution parsing, per‑paper role, and network centrality), run an iterative author‑evolution agent to (a) fetch full‑text author contribution sections, (b) compute contribution weights, and (c) generate a coauthor network.

Feedback:

Updated: March 10, 2026

BGPT Author Review

Scientific Quality

70%

Demonstrates strong experimental skills and meaningful contributions to high‑impact, multidisciplinary virology work; score reduced because much of the impact is through collaborative middle‑author roles rather than a larger set of independent first‑author flagship studies and because several works rely on in vitro/surrogate systems with stated translational limits.

Communication Quality

80%

Papers are published in high‑visibility journals with clear methods and reproducible experimental descriptions; author also published first‑author mechanistic work, indicating above‑average clarity and methodological transparency.

Author Novelty

70%

Contributions are innovative within virology (e.g., reconstructing extinct env entry, surrogate systems), but novelty is often as part of larger teams rather than solo conceptual breakthroughs.

Scientific Rigor

80%

Methodologically rigorous papers with appropriate controls, sequencing validation, structural/biochemical corroboration, and explicit discussion of limitations; reproducibility is supported by standard assays and multiple orthogonal methods.

Top Data Sources Export MCP

1. The study reports the creation and characterization of a replication-competent recombinant vesicular stomatitis virus (rVSV) expressing dairy-cattle H5N1 HA and NA as a safe BSL-2 surrogate to study antibody neutralization, antibody escape mutations, and resistance to neuraminidase inhibitors, informing rapid pandemic preparedness and evaluation of countermeasures. [2025]

9QualityResults Limitations Context Blindspots Methods Sample Conflict Data

↗ Paper Review ↗ Full Paper

Key Insight

Embedding rigorous surrogate systems and diagnostic artifact studies into collaborative, high‑impact teams accelerates rapid response research, but formal cross‑validation against authentic pathogens is essential to translate in vitro insights into reliable public health actions.

Keep Exploring

Fetch and parse author contribution statements for each paper to quantify Robinson‑McCarthy's role (experiments, analysis, writing).

Compute coauthorship network centrality and identify whether the author acts as a methodological bridge between structural biology and infectious disease labs.

Analysis Wizard

Preparing code to fetch OpenAlex metadata + compute per‑paper contribution weights and coauthor centrality to quantify Robinson‑McCarthy's collaborative role.

Hypothesis Graveyard

Hypothesis: Middle‑author status implies minor experimental role — falsified because first‑ and middle‑author positions in large virology teams often reflect significant experimental contributions; attribution requires the author contribution sections rather than positional inference.

Hypothesis: Surrogate systems are equivalent to authentic viruses — falsified by explicit limitations reported in surrogate papers indicating differential neutralization for stem‑directed mAbs and potential differences in glycoprotein presentation.

Potential Experiments

Directly compare neutralization of matched panel of head‑ and stem‑directed mAbs against authentic H5N1, rVSV‑H5N1 surrogate, and HA‑pseudotyped lentivirus across identical assay conditions to quantify systematic biases and derive conversion functions.

Perform blinded diagnostic plate runs spiking known concentrations of laboratory‑generated DNA/RNA and blinded clinical samples across multiple labs to measure false positive rates and validate molecular barcoding mitigation strategies.

Science Art

Science Movie

Make a narrated HD Science movie for this answer ($32 per minute)

Discussion

BGPT Bias

I emphasize experimental reproducibility and methodological transparency and may undervalue qualitative leadership not evident from bibliometrics.

Stay current without chasing every paper.

Know what changed, what holds up, and what remains uncertain. Every Friday. No ads.

Check Claims Before You Publish

See how your reported results read as versioned evidence records — linked to experiments and limitations.Know what the science actually supports before you trust the answer.